Tag Archives: Biomarkers

28Aug/24

FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies

Reasearch, , , , , ,

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval of its in vitro diagnostic (IVD) TruSight™ Oncology (TSO) Comprehensive test and its first two companion diagnostic (CDx) indications. This single test interrogates over 500 genes to profile a patient’s solid tumor, helping to increase the likelihood of identifying an immuno-oncology biomarker or clinically actionable biomarkers that enable targeted therapy options or clinical trial enrollment. Continue reading

05Oct/23

Large-scale proteomics in population-based studies from UK and Iceland

Reasearch, , , , , , , , ,

n an article revealed today in Nature, scientists from deCODE Genetics, a subsidiary of the pharmaceutical company Amgen, demonstrated how plasma proteomics can contribute to a better understanding of diseases. The study’s focus on the plasma proteome led the team to find associations between various diseases and the levels of specific proteins. “Measuring a great number of proteins in a population-based cohort enables the discovery of circulating biomarkers and the early detection of disease,” says Patrick Sulem, scientist at deCODE genetics and one of the senior authors on the paper. Continue reading